Clinical Trials in Michigan

Showing 3661-3680 of 16,154 trials

The Impact of Light Exposure on Cognitive Function in Classrooms

NCT06325150

Humans are constantly exposed to a variety of light types, created naturally or through artificial means. Light exposure captured by the eyes impacts many physiological functions in humans, including but not limited to cognitive output, fatigue levels, and mood regulation. The level of impact on cognitive learning from different types of light on undergraduate adult students remains unclear.

Healthy

Michigan State University300 participantsStarted May 2026

East Lansing, Michigan, United States

TERMINATEDPhase 358 miles

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

NCT03467958

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.

Crohn Disease

Celgene854 participantsStarted Aug 2018

Peoria, Arizona, United States • Scottsdale, Arizona, United States • North Little Rock, Arkansas, United States +763 more locations

The Impact of Light Exposure on Cognitive Function in Classrooms

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Find Trials by Condition in Michigan

BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Ascending Dose Study of FrontlineODP™ Spray Dried Plasma

A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery

Omnipod 5 System Compared to Pump Therapy

PRO 140 in Treatment-Experienced HIV-1 Subjects

EASE: The Materna Prep Pivotal Study

BlueWind RENOVA iStim™ System for the Treatment of OAB

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

Focused Suicide Prevention Strategy for Youth Presenting to the Emergency Department With Suicide Related Behaviour

Promising ROd-cone DYstrophy Gene therapY

Veterans Response to Dosage in Chiropractic Therapy

Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs